Key result
The triglyceride-glucose index is associated with a more favorable prognosis in patients with hypertrophic cardiomyopathy and heart failure with preserved ejection fraction.
Why the study?
Does the triglyceride-glucose (TyG) index predict prognosis in patients with hypertrophic cardiomyopathy and heart failure with preserved ejection fraction?
Does the triglyceride-glucose (TyG) index predict prognosis in patients with hypertrophic cardiomyopathy and heart failure with preserved ejection fraction?
The authors argue that the counterintuitive association between the TyG index and prognosis in HCM-HFpEF may reflect a compensatory metabolic shift rather than solely a marker of dysfunction.
†These authors contributed equally. *Joint senior authors.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2026) conducted a letter in Hypertrophic cardiomyopathy (HCM) and heart failure with preserved ejection fraction (HFpEF). Triglyceride-glucose (TyG) index was evaluated on All-cause and cardiovascular mortality. The triglyceride-glucose index is associated with a more favorable prognosis in patients with hypertrophic cardiomyopathy and heart failure with preserved ejection fraction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: